Endocrinology

NCI-CCC Myeloma Tumor Board Question

Questions discussed in this category

For patients with mild CKD, how do you decide between zoledronic acid and denosumab for bone protection in patients with multiple myeloma?

For pts w/ eGFR between 30-60

1 Answer available

Related Topics in Endocrinology